Anti-IL-22RA antibodies and binding partners and methods of using in inflammation

Details for Australian Patent Application No. 2004223837 (hide)

International Classifications

Event Publications

13 October 2005 PCT application entered the National Phase

PCT publication WO2004/085476 Priority application(s): WO2004/085476

20 October 2005 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 23 Sep 2005

24 November 2005 Section 223 Application Received

ZymoGenetics, Inc. An application to extend the time from 06 Oct 2004 to 06 Oct 2005 in which to comply with Section 6(c) has been filed . Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 2005

19 January 2006 Section 223 Application Allowed

ZymoGenetics, Inc. The time in which to comply with Section 6(c) has been extended to 06 Oct 2005. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 2005

21 April 2011 Application Accepted

Published as AU-B-2004223837

18 August 2011 Standard Patent Sealed

27 October 2011 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 22 Aug 2011. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 2005

15 March 2012 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 22 Aug 2011

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.